evaluation for effect of perforator deep vein ligation in side to side cubital arteriovenous fistula in kidney dialysis patients.

Comparative evaluation for effect of perforator deep vein ligation in maturation and complications of side to side cubital arteriovenous fistula in kidney dialysis patients.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20080907001224N2

Enrollment

Registered

2019-11-24

Start date

2019-01-21

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease, stage 5. Chronic kidney disease, stage 5

Interventions

Intervention 1: Intervention group: Patients in this group will undergo deep vein perforator ligation with silk suture 3.0. Intervention 2: Control group: Patients in this group will not undergo deep

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Informed consent Age>18 Having general conditions for the creation of arteriovenous fistula No history of hypotension

Exclusion criteria

Exclusion criteria: Dissatisfaction with the patient to continue the study The absence of appropriate anatomical criteria for an appropriate side to side anastomosis. (during surgery) End-side anastomosis based on anatomical criteria during surgery

Design outcomes

Primary

Measure	Time frame
Cephalic vein maturation and Suitability for hemodialysis based on doppler ultrasonography. Timepoint: 1 week, 1 month, 3 months. Method of measurement: Maturation criteria based on the color doppler sonography is :flow >600 milliliter/Minute, cephalic length >10 Centimeters Or Two 4 Centimeters Segments; cephalic diameters>6 millimeters and < 5 millimeters Deep From Skin Surface.;Venous hypertension. Timepoint: 1 week, 1 month, 3 months. Method of measurement: The excessive flow of intravenous retrograde leads to intravenous hypertension, which is accompanied by a change in the color of the blue, edema, dilatation of the veins and the color change of the organ in the physical examination.;Steal syndrome. Timepoint: 1 week, 1 month, 3 months. Method of measurement: Steal syndrome refers to the diversion of arterial flow into another vascular bed, which does not meet the tissue needs of the target organ, and is manifested by symptoms such as pain, weakness, tissue loss and ulcers in the physical examination.;General Surgical Complications. Timepoint: 1 week, 1 month, 3 months. Method of measurement: Complications such as infection, seroma and hematoma are detected in a physical examination.	—

Measure

Time frame

Cephalic vein maturation and Suitability for hemodialysis based on doppler ultrasonography. Timepoint: 1 week, 1 month, 3 months. Method of measurement: Maturation criteria based on the color doppler sonography is :flow >600 milliliter/Minute, cephalic length >10 Centimeters Or Two 4 Centimeters Segments; cephalic diameters>6 millimeters and < 5 millimeters Deep From Skin Surface.;Venous hypertension. Timepoint: 1 week, 1 month, 3 months. Method of measurement: The excessive flow of intravenous retrograde leads to intravenous hypertension, which is accompanied by a change in the color of the blue, edema, dilatation of the veins and the color change of the organ in the physical examination.;Steal syndrome. Timepoint: 1 week, 1 month, 3 months. Method of measurement: Steal syndrome refers to the diversion of arterial flow into another vascular bed, which does not meet the tissue needs of the target organ, and is manifested by symptoms such as pain, weakness, tissue loss and ulcers in the physical examination.;General Surgical Complications. Timepoint: 1 week, 1 month, 3 months. Method of measurement: Complications such as infection, seroma and hematoma are detected in a physical examination.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHasan Ravari

Mashhad University of Medical Sciences

ravarih@mums.ac.ir+98 51 3851 3258

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026